Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL16197955 | 0.98 | TSHR (0.38) | TSHRALDH1A1CYP3A4TDP1GAA | |
| Ether SCHEMBL16197952 | 0.96 | ALDH1A1 (0.36) | TSHRALDH1A1CYP3A4TDP1GAA | |
| SCHEMBL27899954 | 0.84 | ALDH1A1 (0.38) | TSHRALDH1A1CYP3A4HPGDLTA4H | |
| SCHEMBL527563 | 0.83 | — | — | |
| SCHEMBL2304698 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| Water SCHEMBL4228027 | 0.82 | KDM4E (0.32) | ALDH1A1HPGD | |
| SCHEMBL28024394 | 0.79 | NR5A1 (0.35) | TSHRALDH1A1CYP3A4TDP1SMN1; SMN2 | |
| SCHEMBL1760841 | 0.78 | CTRC (0.39) | ALDH1A1CYP3A4TDP1GAAL3MBTL1 | |
| SCHEMBL2578095 | 0.77 | HIF1A (0.40) | TSHRCYP3A4TDP1HTTNR1H2 | |
| SCHEMBL527183 | 0.76 | HSD17B3 (0.32) | TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105801528-B | With metal catalyst reduction HMF ether | 阿彻丹尼尔斯米德兰德公司 | 2019-06-21 | — | — | CN | disclosed |
| EP-2784069-B2 | Oxidation of 5-alkoxy-furfural to 5-(alkoxycarbonyl)furan-2-carboxylic acid | ARCHER DANIELS MIDLAND CO (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-3133064-B1 | PROCESS FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID (FDCA) BY OXIDATION OF 5-(ALKYLOXYMETHYL)FURFURAL (AMF) WITH OXYGEN IN THE PRESENCE OF A CO(II) OR CE(III) CATALYST, A BROMIDE SALT AND A SOLVENT | ARCHER DANIELS MIDLAND CO (US) | 2019-03-20 | — | — | EP | disclosed |
| EP-3257845-A1 | PREPARATION OF 2,5-FURANDICARBOXYLIC ACID BY OXIDATION OF 5-(ACETOXYMETHYL)FURFURAL IN THE PRESENCE OF A BROMIDE, OXYGEN AND A COBALT(II) OR CERIUM(III) CATALYST | Archer Daniels Midland Company (US) | 2017-12-20 | — | — | EP | disclosed |
| US-9783516-B2 | Reduction of HMF ethers with metal catalyst | ARCHER DANIELS MIDLAND CO. (US) | 2017-10-10 | — | — | US | disclosed |
| US-9643945-B2 | Process for the preparation of 2,5-furan-dicarboxylic acid | FURANIX TECHNOLOGIES B.V. (NL) | 2017-05-09 | — | — | US | disclosed |
| CN-104744414-B | Oxidation Of Furfural Compounds | 阿彻丹尼尔斯米德兰德公司 | 2017-04-12 | — | — | CN | disclosed |
| EP-3133064-A1 | PROCESS FOR THE PREPARATION OF 2,5-FURANDICARBOXYLIC ACID (FDCA) BY OXIDATION OF 5-(HYDROXYMETHYL)FURFURAL (HMF) OR 5-(ALKYLOXYMETHYL)FURFURAL (AMF) WITH OXYGEN IN THE PRESENCE OF A CO(II) OR CE(III) CATALYST, A BROMIDE SALT AND A SOLVENT | Archer Daniels Midland Company (US) | 2017-02-22 | — | — | EP | disclosed |
| CN-103626639-B | With metal catalyst reduction HMF ether | 阿彻丹尼尔斯米德兰德公司 | 2016-12-07 | — | — | CN | disclosed |
| EP-2981528-B1 | PROCESS FOR THE PREPARATION OF 2,5-FURAN-DICARBOXYLIC ACID | FURANIX TECHNOLOGIES BV (NL) | 2016-11-30 | — | — | EP | disclosed |
| CN-101827833-A | Mixture of furfural and 5-(alkoxymethyl)furfural derivatives from sugars and alcohols | FURANIX TECHNOLOGIES BV | 2010-09-08 | — | — | CN | disclosed |
| EP-2197868-A2 | HYDROXYMETHYLFURFURAL ETHERS FROM SUGARS OR HMF AND MIXED ALCOHOLS | Furanix Technologies B.V (NL) | 2010-06-23 | — | — | EP | disclosed |
| WO-2010062689-A2 | REDUCTION OF HMF ETHERS WITH METAL CATALYST | ARCHER DANIELS MIDLAND COMPANY (US) | 2010-06-03 | — | — | WO | disclosed |
| US-20100058650-A1 | For example, 5-ethoxymethylfurfural; use of mixed alcohols in reaction mixture to prevent product crystallization; end use as renewable biofuel or fuel additive, or as renewable raw material to make monomers such as furandicarboxylic acid | FURANIX TECHNOLOGIES B.V. (NL) | 2010-03-11 | — | — | US | disclosed |
| WO-2009030508-A2 | HYDROXYMETHYLFURFURAL ETHERS FROM SUGARS OR HMF AND MIXED ALCOHOLS | FURANIX TECHNOLOGIES B.V. (NL) | 2009-03-12 | — | — | WO | disclosed |
| US-20090053780-A1 | Enzymatic oxidation of HMF | ARCHER DANIELS MIDLAND CO. | 2009-02-26 | — | — | US | disclosed |
| WO-2009023174-A2 | ENZYMATIC OXIDATION OF HMF | ARCHER DANIELS MIDLAND COMPANY (US) | 2009-02-19 | — | — | WO | disclosed |
| US-20080221236-A1 | Furanic grouts | BATTELLE MEMORIAL INSTITUTE | 2008-09-11 | — | — | US | disclosed |
| US-20080207796-A1 | Furanic resin aggregate binders and method | BATTELLE MEMORIAL INSTITUTE | 2008-08-28 | — | — | US | disclosed |
| US-20080207795-A1 | Binder Formulations Utilizing Furanic Components | BATTELLE MEMORIAL INSTITUTE | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090053780-A1 | Enzymatic oxidation of HMF | AOX1, ADH1C, HPD | TSHR 2584/4885ALDH1A1 26/4885CYP3A4 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.